Kidney cancer treatment with targeted therapy

Kidney cancer treatment with targeted drugs stops tumor growth, spreads metastases, and transfers the disease to the remission stage. Such drugs are mainly indicated for patients who, for health reasons, cannot tolerate traditional chemotherapy – weakened and older patients. In kidney cancer, targeted therapy increases patients' overall and relapse-free survival. In addition, it provides them with a good quality of life due to low toxicity. Each targeted drug has a specific "target" – a vital molecule for cancer cells. Malignant tumors always contain a large number of vessels because they grow fast and need to receive more blood. In malignant kidney tumors, targeted drugs inhibit the growth of new vessels (the tumor needs them to receive oxygen and nutrients) and proteins that stimulate the reproduction of cancer cells. As a result, the disease stops progressing, and the neoplasm decreases in size. Drugs for targeted therapy are selected individually, depending on the sensitivity of tumor cells to them. The doctor prescribes medication courses for several weeks with breaks for recovery.